Parean Biotechnologies

Parean Biotechnologies is an integrated technological platform founded in 2020 that specializes in deciphering immune and tumor cell functions for the pharmaceutical and biotechnology sectors. The company combines advanced wet lab capabilities—such as cytometry, cell sorting, and bulk or single-cell omics library generation—with AI-powered data science to provide comprehensive analytical services. By integrating these disciplines, Parean supports researchers in navigating complex biological protocols and generates high-quality readouts for applications in cell therapy, biologics, and biomarker discovery. Their platform is 10x Genomics certified and operates under ISO 9001 standards, enabling them to act as an outsourced research partner for experimental design and data interpretation.

Parean serves a vital role for customers by accelerating research programs and driving discoveries in oncology and immune-related diseases. They provide flexible partnering models, ranging from long-term co-development and research outsourcing to specific commercial alliances, such as their collaboration with Keyrus Life Science for data science and Immudex for antigen-specific T and B cell characterization. By offloading the complexities of immune repertoire research, omics data analysis, and biostatistics to a dedicated expert team, pharmaceutical and biotech clients can focus on clinical milestones and therapeutic development. Their proven impact is evidenced by numerous scientific publications and ongoing involvement in multi-year collaborative research programs.